Management of patients undergoing rhinoplasty while receiving anticoagulant therapy

Roberto Bracaglia, Damiano Tambasco, Marco D'Ettorre, Stefano Gentileschi

Research output: Contribution to journalArticle

2 Citations (Scopus)


A proper bloodless field and coagulation profile represent essential elements for performing a safe, effective, and fast rhinoplasty. However, some particular conditions among patients with a high thromboembolic risk for congenital thrombophilia require antithrombotic prophylaxis using low-molecular-weight heparin. To date, the literature contains no particular indication for the management of patients undergoing rhinoseptoplasty while receiving anticoagulant therapy. The authors report their experience managing a 36-year-old man who underwent aesthetic rhinoseptoplasty while at the same time carrying a heterozygous mutation (G20210A) of prothrombin and a homozygous mutation of methylenetetrahydrofolate reductase (C677T). Special attention must be paid to balancing the prevention and reduction of thrombotic risk for excessive anticoagulation, which would make surgery unsafe and difficult to perform. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article.
Original languageEnglish
Pages (from-to)1087-1089
Number of pages3
JournalAesthetic Plastic Surgery
Publication statusPublished - 2012


  • Adult
  • Anticoagulants
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Mutation
  • Prothrombin
  • Rhinoplasty
  • Risk Factors
  • Thrombophilia


Dive into the research topics of 'Management of patients undergoing rhinoplasty while receiving anticoagulant therapy'. Together they form a unique fingerprint.

Cite this